Dan Vogl
Director, Abramson Cancer Center Clinical Research Unit · Penn Medicine
Credentials: · · · ·
History
PresentAbramson Cancer Center Clinical Research Unit · Penn Medicine
NewYork–Presbyterian Hospital
NewYork-Presbyterian/Columbia University Medical Center
Research
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy · 2016 · 4,439 citations
Nature Medicine · 2015 · 722 citations
Science Immunology · 2016 · 676 citations
60 papers
33 papers
30 papers
18 papers
- AW
17 papers · 2 as a fellow
16 papers
14 papers
14 papers
Grants
- 2025–2029
Purinergic Receptors in Myeloma
National Cancer Institute · R01
PI · $1.2M · University of Pennsylvania
- 1997–2025
Abramson Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $7.7M · University of Pennsylvania
- 2016–2018
Regulation of Multiple Myeloma by S100A9 Protein
National Cancer Institute · R21
PI · $467.8K · Wistar Institute
- 2009–2014
Improving Current Therapies for Myeloma
National Cancer Institute · K23
Contact PI · $861.8K · University of Pennsylvania
Clinical trials
- 2020–2025
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
Principal investigator · Terminated · Phase 1
University of Pennsylvania
- 2013
Principal investigator · Completed
Abramson Cancer Center at Penn Medicine
- 2012–2015
Autophagy Induction After Bortezomib for Myeloma
Principal investigator · Completed · Early phase 1
Abramson Cancer Center at Penn Medicine
- 2011–2012
Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine
Principal investigator · Completed · Early phase 1
Abramson Cancer Center at Penn Medicine